A
Price
$113.99
Change
-$2.37 (-2.04%)
Updated
Jul 18 closing price
Capitalization
42.66B
37 days until earnings call
CNMD
Price
$47.64
Change
-$1.61 (-3.27%)
Updated
Jul 18 closing price
Capitalization
2.43B
9 days until earnings call
Interact to see
Advertisement

A vs CNMD

Header iconA vs CNMD Comparison
Open Charts A vs CNMDBanner chart's image
Agilent Technologies
Price$113.99
Change-$2.37 (-2.04%)
Volume$1.52M
Capitalization42.66B
CONMED
Price$47.64
Change-$1.61 (-3.27%)
Volume$476.41K
Capitalization2.43B
A vs CNMD Comparison Chart in %
Loading...
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CNMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
A vs. CNMD commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a Hold and CNMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (A: $113.99 vs. CNMD: $47.64)
Brand notoriety: A and CNMD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: A: 73% vs. CNMD: 130%
Market capitalization -- A: $42.66B vs. CNMD: $2.43B
A [@Medical Specialties] is valued at $42.66B. CNMD’s [@Medical Specialties] market capitalization is $2.43B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 1 FA rating(s) are green whileCNMD’s FA Score has 1 green FA rating(s).

  • A’s FA Score: 1 green, 4 red.
  • CNMD’s FA Score: 1 green, 4 red.
According to our system of comparison, A is a better buy in the long-term than CNMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 4 TA indicator(s) are bullish while CNMD’s TA Score has 4 bullish TA indicator(s).

  • A’s TA Score: 4 bullish, 5 bearish.
  • CNMD’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, A is a better buy in the short-term than CNMD.

Price Growth

A (@Medical Specialties) experienced а -7.54% price change this week, while CNMD (@Medical Specialties) price change was -7.08% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.11%. For the same industry, the average monthly price growth was +2.74%, and the average quarterly price growth was -1.25%.

Reported Earning Dates

A is expected to report earnings on Aug 27, 2025.

CNMD is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Medical Specialties (-0.11% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
A($42.7B) has a higher market cap than CNMD($2.43B). CNMD has higher P/E ratio than A: CNMD (38.71) vs A (34.82). A YTD gains are higher at: -14.789 vs. CNMD (-29.898). A has higher annual earnings (EBITDA): 1.69B vs. CNMD (192M). CNMD has less debt than A: CNMD (974M) vs A (2.56B). A has higher revenues than CNMD: A (6.74B) vs CNMD (1.25B).
ACNMDA / CNMD
Capitalization42.7B2.43B1,756%
EBITDA1.69B192M880%
Gain YTD-14.789-29.89849%
P/E Ratio34.8238.7190%
Revenue6.74B1.25B541%
Total CashN/A24.3M-
Total Debt2.56B974M262%
FUNDAMENTALS RATINGS
A vs CNMD: Fundamental Ratings
A
CNMD
OUTLOOK RATING
1..100
246
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
8
Undervalued
PROFIT vs RISK RATING
1..100
69100
SMR RATING
1..100
4860
PRICE GROWTH RATING
1..100
6185
P/E GROWTH RATING
1..100
6596
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CNMD's Valuation (8) in the Medical Specialties industry is in the same range as A (20) in the Biotechnology industry. This means that CNMD’s stock grew similarly to A’s over the last 12 months.

A's Profit vs Risk Rating (69) in the Biotechnology industry is in the same range as CNMD (100) in the Medical Specialties industry. This means that A’s stock grew similarly to CNMD’s over the last 12 months.

A's SMR Rating (48) in the Biotechnology industry is in the same range as CNMD (60) in the Medical Specialties industry. This means that A’s stock grew similarly to CNMD’s over the last 12 months.

A's Price Growth Rating (61) in the Biotechnology industry is in the same range as CNMD (85) in the Medical Specialties industry. This means that A’s stock grew similarly to CNMD’s over the last 12 months.

A's P/E Growth Rating (65) in the Biotechnology industry is in the same range as CNMD (96) in the Medical Specialties industry. This means that A’s stock grew similarly to CNMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACNMD
RSI
ODDS (%)
Bearish Trend 3 days ago
51%
Bullish Trend 3 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
57%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bearish Trend 3 days ago
55%
Bearish Trend 3 days ago
69%
MACD
ODDS (%)
Bearish Trend 3 days ago
48%
Bearish Trend 3 days ago
68%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
61%
Bearish Trend 3 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
63%
Bearish Trend 3 days ago
73%
Advances
ODDS (%)
Bullish Trend 4 days ago
61%
Bullish Trend 11 days ago
73%
Declines
ODDS (%)
Bearish Trend 6 days ago
60%
Bearish Trend 3 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
83%
Aroon
ODDS (%)
Bullish Trend 3 days ago
61%
Bearish Trend 3 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CNMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSGZX81.380.22
+0.27%
Columbia Seligman Global Tech Inst
JDVNX24.340.02
+0.08%
JHancock Disciplined Value NAV
HGXVX16.64N/A
N/A
Hartford Global Impact R6
APDNX17.33-0.04
-0.23%
Artisan Select Equity Advisor
GSSUX40.73-0.18
-0.44%
Goldman Sachs Small Cap Value R6

A and

Correlation & Price change

A.I.dvisor indicates that over the last year, A has been closely correlated with MTD. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if A jumps, then MTD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To A
1D Price
Change %
A100%
-2.04%
MTD - A
85%
Closely correlated
+0.90%
TMO - A
80%
Closely correlated
-2.41%
RVTY - A
80%
Closely correlated
-2.36%
WAT - A
79%
Closely correlated
-3.24%
BRKR - A
78%
Closely correlated
-3.89%
More

CNMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNMD has been loosely correlated with NVST. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CNMD jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNMD
1D Price
Change %
CNMD100%
-3.27%
NVST - CNMD
52%
Loosely correlated
-1.22%
SHC - CNMD
49%
Loosely correlated
-1.51%
RVTY - CNMD
48%
Loosely correlated
-2.36%
AZTA - CNMD
47%
Loosely correlated
-2.96%
A - CNMD
45%
Loosely correlated
-2.04%
More